SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Doug Bean who wrote (1600)1/21/2000 1:40:00 PM
From: vestor  Read Replies (1) | Respond to of 1837
 
I too am wondering. It would certainly increase sales of Cenestin..... Lets e-mail the company !



To: Doug Bean who wrote (1600)1/27/2000 10:10:00 AM
From: vestor  Read Replies (2) | Respond to of 1837
 
Hey Doug,
Here are the figures for we Sunday.

"C" to "P" ratio was .622 of 1 %. This a new record high.

Apri script sales were 1,162. This is a new weekly high.

All in all market penetration continues on both drugs.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News